| 1.84 0.06 (3.37%) | 04-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 507.44  |
1-year : | 819.93 |
| Resists | First : | 434.45 |
Second : | 702 |
| Pivot price | 2.49 |
|||
| Supports | First : | 1.62 |
Second : | 1.34 |
| MAs | MA(5) : | 1.98 |
MA(20) : | 2.99 |
| MA(100) : | 292.13 |
MA(250) : | 253.66 |
|
| MACD | MACD : | -46.6 |
Signal : | -56.3 |
| %K %D | K(14,3) : | 1.6 |
D(3) : | 1.5 |
| RSI | RSI(14): 32.6 |
|||
| 52-week | High : | 760.5 | Low : | 1.62 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ RDGT ] has closed above bottom band by 25.2%. Bollinger Bands are 98.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.87 - 1.89 | 1.89 - 1.9 |
| Low: | 1.59 - 1.61 | 1.61 - 1.62 |
| Close: | 1.82 - 1.84 | 1.84 - 1.86 |
Ridgetech Inc operates as a holding company. The Company, through its subsidiaries, wholesales, distributes, and retails pharmaceutical and other healthcare products.
Thu, 16 Apr 2026
Why Ridgetech (RDGT) Stock Is Popular (Institutional Demand) 2026-04-16 - Expert Momentum Signals - UBND thành phố Hải Phòng
Sat, 11 Apr 2026
What's Going On With Ridgetech Stock Friday? - Sahm
Tue, 07 Apr 2026
RDGT Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Tue, 07 Apr 2026
Ridgetech Announces 1-for-150 Reverse Share Split to Take Effect April 7, 2026 - TipRanks
Fri, 03 Apr 2026
Ridgetech (NASDAQ: RDGT) to execute 1-for-150 reverse share split - Stock Titan
Fri, 03 Apr 2026
Ridgetech, Inc. Announces 1-for-150 Reverse Share Split - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 1 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 4 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -54.62 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 762.9 |
| Profit Margin | 10.3 % |
| Operating Margin | -0.2 % |
| Return on Assets (ttm) | -1.3 % |
| Return on Equity (ttm) | -8.1 % |
| Qtrly Rev. Growth | -11.7 % |
| Gross Profit (p.s.) | 4.32 |
| Sales Per Share | 133.42 |
| EBITDA (p.s.) | -0.97 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 17 (M) |
| Levered Free Cash Flow | 6 (M) |
| PE Ratio | -0.04 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.01 |
| Price to Cash Flow | 0.09 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|